PT2735316T - Novas abordagens terapêuticas para tratamento de doenças neuroinflamatórias - Google Patents
Novas abordagens terapêuticas para tratamento de doenças neuroinflamatóriasInfo
- Publication number
- PT2735316T PT2735316T PT141560482T PT14156048T PT2735316T PT 2735316 T PT2735316 T PT 2735316T PT 141560482 T PT141560482 T PT 141560482T PT 14156048 T PT14156048 T PT 14156048T PT 2735316 T PT2735316 T PT 2735316T
- Authority
- PT
- Portugal
- Prior art keywords
- new therapeutic
- therapeutic approaches
- neuroinflammatory conditions
- treating neuroinflammatory
- treating
- Prior art date
Links
- 238000013459 approach Methods 0.000 title 1
- 230000002314 neuroinflammatory effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09305265A EP2236158A1 (en) | 2009-03-30 | 2009-03-30 | New therapeutic approaches for treating neuroinflammatory conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2735316T true PT2735316T (pt) | 2017-01-10 |
Family
ID=41463183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT141560482T PT2735316T (pt) | 2009-03-30 | 2010-03-29 | Novas abordagens terapêuticas para tratamento de doenças neuroinflamatórias |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8642566B2 (pt) |
| EP (3) | EP2236158A1 (pt) |
| CY (1) | CY1118455T1 (pt) |
| DK (1) | DK2735316T3 (pt) |
| ES (2) | ES2530847T3 (pt) |
| HR (1) | HRP20161794T1 (pt) |
| HU (1) | HUE032356T2 (pt) |
| LT (1) | LT2735316T (pt) |
| PL (1) | PL2735316T3 (pt) |
| PT (1) | PT2735316T (pt) |
| SI (1) | SI2735316T1 (pt) |
| SM (1) | SMT201600479B (pt) |
| WO (1) | WO2010115741A2 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2535046A1 (en) * | 2011-06-17 | 2012-12-19 | Institut Pasteur | Use of mecamylamine in the treatment of pathogen-infected patients with central nervous system disorder |
| EP3052189A4 (en) * | 2013-10-03 | 2017-11-01 | Leuvas Therapeutics | Modulation of leukocyte activity in treatment of neuroinflammatory degenerative disease |
| KR101809379B1 (ko) * | 2016-10-13 | 2017-12-14 | 연세대학교 산학협력단 | 디오스민 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물 |
| CN113329753A (zh) * | 2019-04-18 | 2021-08-31 | 列日大学 | 用于预防和治疗革兰氏阴性细菌感染、污染和污垢的新型嘧啶衍生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8569277B2 (en) * | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
-
2009
- 2009-03-30 EP EP09305265A patent/EP2236158A1/en not_active Withdrawn
-
2010
- 2010-03-29 SI SI201031363A patent/SI2735316T1/sl unknown
- 2010-03-29 ES ES10711227T patent/ES2530847T3/es active Active
- 2010-03-29 PT PT141560482T patent/PT2735316T/pt unknown
- 2010-03-29 US US13/260,773 patent/US8642566B2/en not_active Expired - Fee Related
- 2010-03-29 LT LTEP14156048.2T patent/LT2735316T/lt unknown
- 2010-03-29 ES ES14156048.2T patent/ES2609962T3/es active Active
- 2010-03-29 HU HUE14156048A patent/HUE032356T2/en unknown
- 2010-03-29 WO PCT/EP2010/054068 patent/WO2010115741A2/en active Application Filing
- 2010-03-29 EP EP14156048.2A patent/EP2735316B1/en active Active
- 2010-03-29 PL PL14156048T patent/PL2735316T3/pl unknown
- 2010-03-29 EP EP10711227.8A patent/EP2413970B1/en not_active Not-in-force
- 2010-03-29 DK DK14156048.2T patent/DK2735316T3/en active
-
2016
- 2016-12-28 HR HRP20161794TT patent/HRP20161794T1/hr unknown
- 2016-12-30 SM SM201600479T patent/SMT201600479B/it unknown
-
2017
- 2017-01-03 CY CY20171100003T patent/CY1118455T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE032356T2 (en) | 2017-09-28 |
| HRP20161794T1 (hr) | 2017-03-10 |
| DK2735316T3 (en) | 2017-01-23 |
| US8642566B2 (en) | 2014-02-04 |
| LT2735316T (lt) | 2017-04-10 |
| PL2735316T3 (pl) | 2017-06-30 |
| EP2413970B1 (en) | 2015-01-07 |
| US20120108528A1 (en) | 2012-05-03 |
| ES2609962T3 (es) | 2017-04-25 |
| EP2735316A1 (en) | 2014-05-28 |
| EP2735316B1 (en) | 2016-10-05 |
| ES2530847T3 (es) | 2015-03-06 |
| CY1118455T1 (el) | 2017-07-12 |
| WO2010115741A2 (en) | 2010-10-14 |
| SMT201600479B (it) | 2017-03-08 |
| EP2236158A1 (en) | 2010-10-06 |
| EP2413970A2 (en) | 2012-02-08 |
| SI2735316T1 (sl) | 2017-05-31 |
| WO2010115741A3 (en) | 2010-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL219412A0 (en) | New therapeutic approaches for treating alzheimer disease | |
| IL224771A (en) | Skin Care Device | |
| HUE047994T2 (hu) | Bardoxolon-metil elhízás kezelésére | |
| IL216013A (en) | Dermatologic Treatment Devices | |
| IL214919A0 (en) | Method for therapeutic use | |
| HK1172257A1 (en) | Combination therapy for treating proliferative diseases | |
| EP2621498A4 (en) | COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS | |
| IL218633A0 (en) | Methods for treating psoriasis | |
| EP2453896A4 (en) | PROCESS FOR TREATING SCHIZOPHRENIA | |
| ZA201204845B (en) | Agents for treating disease | |
| EP2427183A4 (en) | THERAPEUTIC COMPOUNDS | |
| EP2536436A4 (en) | ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMICS | |
| SI2735316T1 (sl) | Novi terapevtski pristopi za zdravljenje nevroinflamatornih stanj | |
| EP2496704A4 (en) | THERAPEUTIC COMPOUNDS | |
| ZA201202379B (en) | Antagonists of dsgs2 for treatment of cancer | |
| ZA201201894B (en) | Pharmaceutical combination for treating tumor | |
| EP2563353A4 (en) | COMPOUNDS FOR ANTIFUNGAL TREATMENT | |
| PL2391366T3 (pl) | Podstawione benzimidazole do leczenia gwiaździaków | |
| EP2456309A4 (en) | THERAPEUTIC COMPOUNDS | |
| GB0906026D0 (en) | Therapeutic compounds | |
| GB0913427D0 (en) | Compounds for treatment of imflammation | |
| GB0911266D0 (en) | Therapeutic compounds | |
| GB0916608D0 (en) | Therapeutic compounds | |
| GB0900712D0 (en) | Therapeutic compounds | |
| GB0916308D0 (en) | Therapeutic compounds |